Similar articles

• In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?

  Andrei G, De Clercq E, Snoeck R. Andrei G, et al. Antiviral Res. 2004 Mar;61(3):181-7. doi: 10.1016/j.antiviral.2003.10.003. Antiviral Res. 2004. PMID: 15168799
• Interactions between virus and antiviral compounds in the host cell.

  Harmenberg J. Harmenberg J. Med Biol. 1984;62(6):299-303. Med Biol. 1984. PMID: 6099858 Review. No abstract available.
• Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.

  Shiraki K, Ogino T, Yamanishi K, Takahashi M. Shiraki K, et al. Biken J. 1983 Mar;26(1):17-23. Biken J. 1983. PMID: 6312958
• [Antiviral resistance of herpes simplex virus and varicella-zoster virus].

  Daikoku T, Shiraki K. Daikoku T, et al. Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:480-6. Nihon Rinsho. 2007. PMID: 17455667 Review. Japanese. No abstract available.
• Thymidine kinase with altered substrate specificity of acyclovir resistant varicella-zoster virus.

  Shiraki K, Ogino T, Yamanishi K, Takahashi M. Shiraki K, et al. Biken J. 1986 Mar;29(1):7-10. Biken J. 1986. PMID: 3022711